BACKGROUND: Recent trials report the efficacy of continuous tenofovir‐based pre‐
exposure prophylaxis (PrEP) for prevention of HIV infection. The cost effectiveness of 'on …

Background. The combination of tenofovir and emtricitabine shows promise as HIV
preexposure prophylaxis (PrEP). We sought to forecast clinical, epidemiologic, and …

Summary Background Pre-exposure prophylaxis (PrEP) with tenofovir and emtricitabine
prevents HIV infections among men who have sex with men (MSM). PrEP can be given on a …

Background. Recent trials report the short-term efficacy of tenofovir-based pre-exposure
prophylaxis (PrEP) for prevention of human immunodeficiency virus (HIV) infection. PrEP's …

Background Substantial gaps remain in understanding the trade-offs between the costs and
benefits of choosing alternative human immunodeficiency virus (HIV) prevention strategies …

Introduction Men who have sex with men (MSM) are disproportionately affected by HIV due
to their increased risk of infection. Oral pre-exposure prophylaxis (PrEP) is a highly effictive …

Objectives: To review the main factors influencing the costs of nondaily oral preexposure
prophylaxis (PrEP) with tenofovir (±emtricitabine). To estimate the cost reductions possible …

Summary Background In the UK, HIV incidence among men who have sex with men (MSM)
has remained high for several years, despite widespread use of antiretroviral therapy and …

Background The efficacy and effectiveness of pre-exposure prophylaxis (PrEP) for
preventing HIV infection acquisition by high-risk men who have sex with men (MSM) is …

Abstract Background. For young South African women at risk for human immunodeficiency
virus (HIV) infection, preexposure prophylaxis (PrEP) is one of the few effective prevention …